Pharmacological strategies in treatment-resistant depression.

Treatment-resistant depression may be due to factors such as co-morbid psychiatric or medical illnesses, chronic psychosocial stresses, and medication nonadherence. Alternative treatment strategies such as optimization, switching to a different antidepressant, augmentation or combination with another antidepressant are strategies useful in such patients. The first strategy in treating resistant depression is to optimize monotherapy. A switch should be made to another agent if there is no response to treatment after an adequate duration. Augmentation and combination strategies are useful if there is sub-optimal response to the initial antidepressant. With several antidepressants (selective serotonin reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors and the newer antidepresssants) and various antidepressant augmentation and combination strategies available to clinicians, the outcome of treating patients with depression should improve.

Psychopathology in sickle cell disease.

Acute and chronic medical conditions are often complicated by psychiatric symptoms. Depression and anxiety are two of the most common psychiatric symptoms that complicate the diagnosis and management of medical conditions. Despite the well-known association between chronic medical conditions and psychiatric diagnoses, psychopathology among individuals with Sickle cell disease (SCD) is not well recognised. The purpose of this article is to examine the relationship between psychiatric symptoms and SCD. We reviewed the existing literature regarding the psychological sequelae among patients with SCD. We then recommend how to better identify and treat psychopathology associated with this condition.

Psychiatric complications of malaria: a case report.

This article reviews the psychiatric complications of malaria. A case of malaria infection is described. The diagnoses, treatment, and neuropsychiatric complications of acute and chronic malaria infection are discussed. The treatment of malaria and its complications are summarized.

Evaluating the tolerability of the newer antidepressants.

Given their equal efficacy, the choice of a specific antidepressant is largely influenced by side effect (SE) profiles. A number of new agents have recently become available. However, data directly comparing the side effects of these agents are scarce. As suggested by AHCPR guidelines, we used the 1998 Physicians' Desk Reference (PDR) to construct a comparison table using treatment emergent, placebo-adjusted incidence rates for the major (gastrointestinal, central nervous system, and sexual) side effects caused by nine antidepressants (fluoxetine, paroxetine, sertraline, fluvoxamine, nefazodone, bupropion SR, mirtazapine, venlafaxine XR, and citalopram). The results were tabulated to show the relative propensity of each drug to cause a particular side effect. Bupropion SR had the most favorable overall side-effect profile, and fluvoxamine the least favorable. However, there are several limitations in using the PDR to compare the newer antidepressants. Clinical studies directly comparing SEs of newer antidepressants are needed. Sexual SEs substantially affected total SE liability. A simplified summary table, with its advantages and some limitations, is not simple to construct. Pitfalls in this process are discussed.

Withdrawal-emergent dyskinesia in a patient on risperidone undergoing dosage reduction.

A 23-year-old, white male with history of paranoid schizophrenia developed a withdrawal-emergent dyskinesia during a dose reduction of risperidone. The implications of this with regard to future risk of tardive dyskinesia (TD) and the potential association of risperidone with TD are discussed.

The physician and unconventional medicine.

BACKGROUND: Unconventional medical therapies, that is, health interventions not normally taught in medical school, consume more than $10 billion per year; yet, little is known of physician involvement with these therapies. METHOD: A national mailed survey of primary care internists with single board certification and of board-certified family physicians was undertaken to determine physician attitude and behavior toward unconventional therapies. The survey identified 16 unconventional therapies. RESULTS: A total of 572 responses were analyzed. These indicated that more than half of these physicians would encourage patients who raise the possibility of unconventional therapy. A large proportion (57%) were willing to refer their patients for treatment for six or more unconventional therapies. CONCLUSIONS: This study indicates considerable physician interest and participation in unconventional medicine, suggesting a need for research and education to help them guide their patients.

The clinical impact of reported variance in potency of antipsychotic agents.

There is significant disagreement on the clinical equivalence (or potency) of antipsychotic agents, with up to 500% variance reported in texts. To address the extent and consequences of these discrepancies, we took a random sample of 18 common psychiatry, psychopharmacology and pharmacology texts for antipsychotic equivalence tables. We found a marked variation in stated equivalences for the majority of antipsychotics. Most affected were the high potency (haloperidol, fluphenazine) and newer (molindone) drugs, which had a 500% variance. This variation inadvertently contributes to the misuse of these agents. For instance, high-potency antipsychotics are prescribed in far larger doses than necessary, leading to decreased efficacy and increased side effects. Steps to simplify and rationalize the use of these agents are recommended.

Factors associated with antidepressant choice.

Previous studies have suggested that nonpsychiatrists tend to prescribe antidepressants (ADs) with the most side effects (SEs), whereas psychiatrists are more likely to prescribe more ADs with fewer SEs. The authors used a questionnaire to examine the antidepressant prescribing pattern, conditions for which ADs were prescribed, and SEs of concern to physicians. Of those surveyed, the psychiatrists reported prescribing significantly more nortriptyline and desipramine, whereas the nonpsychiatrists prescribed more amitriptyline. The nonpsychiatrists were more likely to prescribe ADs for pain, and they were significantly less concerned with orthostatic hypotension. Possible lower dosing and level of concern about orthostatic hypotension may be related. Further study is proposed to assess other factors that might influence AD choice.

Antidepressant side effects and physician prescribing patterns.

We studied the following questions: (1) Do physicians preferentially prescribe antidepressants (ADs) with the least side effects (SEs) of sedation, orthostatic hypotension, and anticholinergic activity; (2) Have there been any recent changes in prescribing patterns; and (3) Do patterns differ for psychiatrists and nonpsychiatrists. Data on psychiatrist and non-psychiatrist outpatient prescribing of specific ADs were obtained from the National Prescription Audit (NPA) for 1986 and 1989. In 1986, physicians did not minimize the use of ADs with the most of these SEs. The 1989 data indicate that psychiatrists made a major change toward prescribing more low SE ADs and less ADs with the most SEs. The data for nonpsychiatrists also suggest some movement in this direction. The availability of fluoxetine and the concomitant focus on SEs may have contributed to this shift. Further investigation is needed to clarify factors that influence physicians' choices of ADs.

Factitious disorders with psychological symptoms.

BACKGROUND: Factitious disorders with psychological symptoms have been underdiagnosed and hence undertreated. Historically, the literature has focused on factitious disorder with physical symptoms, particularly Munchausen's syndrome. METHOD: The authors report three cases of factitious disorder with psychological symptoms that had diverse clinical presentations. RESULTS: Two of the patients had features of a psychiatric Munchausen's syndrome--being middle-aged, aggressive men who falsified their symptoms, treatments, and backgrounds. The third patient was a younger woman with comorbid substance abuse, dysthymia, and borderline personality disorder. CONCLUSION: The authors feel that there is a need for refinement of diagnostic criteria, greater awareness, and evaluation of treatment approaches for this condition.

Comparison of three depression rating scales.

We directly compared scores on the self-rated Beck Depression Inventory with two other common rating scales that assess a wider range of psychopathology, including depression, the self-rated Symptom Check List-90--R (SCL-90--R), and the clinician-rated Brief Psychiatric Rating Scale for 71 inpatients who suffered from depression (n = 50) and other disorders. All measures of depression showed robust correlations among themselves. The self-rated scales correlated better between themselves than with the clinician-rated scale. Since the SCL-90--R assesses depression as well as the Beck inventories, is also a self-report instrument, yet provides a richer description of psychopathology with little extra effort, it may have some advantage over the latter.

Toward a definite diagnosis of Alzheimer's disease.

There is a significant, and growing, number of patients who suffer from dementia of the Alzheimer's type (DAT). However, due to clinical variability and symptom overlap, and despite millions of dollars spent in diagnostic work-ups, the diagnosis of DAT remains one of exclusion or by neuropathologic study (usually postmortem). This report evaluates two promising methods, the newly refined clinical criteria sets (e.g., NINCDS-ADRDA) and single-photon emission computed tomography (SPECT), on their capacity for definite, accurate, and early diagnosis of DAT patients. We found that clinical diagnosis of DAT can achieve a weighted average for sensitivity of 72%, specificity of 86%, and diagnostic confidence of 72%; however, when NINCDS-ADRDA criteria are used, these results improve to 88%, 91%, and 92%, respectively. SPECT scans could differentiate DAT patients from normals with 86% sensitivity, 96% specificity, and 98% diagnostic confidence. Comparable figures for DAT versus multi-infarct dementia (MID) are 82%, 81%, and 86%, respectively. We conclude that, although a definite clinical diagnosis of DAT is still elusive and more research is needed, the use of either NINCDS-ADRDA criteria or SPECT scans may enhance diagnostic accuracy.

The use of antidepressants in the elderly: 1986 and 1989.

Depression is a frequent disorder in the elderly that is often treated with antidepressants. It is generally accepted that, since all antidepressants are equally effective and the elderly are differentially more susceptible to side effects, those antidepressants with the least side effects should be preferentially used. The actual use of antidepressants in 1986 and 1989 was reviewed. We found that (1) contrary to expectation, antidepressants were prescribed in 1986 in quantities that were directly proportional to their side effects, ie, the greater the side effects, the more they were used, and (2) there was a distinct shift to a more thoughtful pattern in 1989. After reviewing the side effect profiles of antidepressants, it is recommended that amitriptyline and doxepin be avoided and that the initial choice be restricted to desipramine, nortriptyline, fluoxetine, and possibly bupropion. This simple change would reduce the relatively high rate of falls and fractures from antidepressant-induced hypotension and of delirium in the elderly. It would also promote increased compliance and greater efficacy, since larger doses will be tolerated.

Adding medications to ongoing psychotherapy: indications and pitfalls.

Research suggests that psychotherapy and psychopharmacology together have benefits beyond those when either is used alone. However, since many patients benefit from psychotherapy alone, medications are not always necessary. Medications should be added when patients are unable to deal with their problems in psychotherapy and their symptoms become troublesome. Drastic clinical deterioration, or increased anxiety or acting out that disrupts ongoing psychotherapy, are other indications. Patients' transference color their attitude towards prescribing, or not prescribing, medications and should be dealt with openly. Some patients equate their being given medications with caring, nurturance, or validation of their suffering. Others see it as an imposition of external controls, or a comment on their psychological weakness. Not being given medications benefits patients who think that the therapist "must be interested in me and not just in my symptoms" or that "I can do it myself." Angry, dependent patients may perceive it as withholding of support, prolongation of agony, not being taken seriously, or not being seen as sick enough. Therapists' countertransference may dictate the addition of medications as a distancing or even punishing maneuver. When prescribing, clinicians should choose specific agents with the least side effects, foster "psychopharmacotherapeutic alliances" to enhance compliance, and educate patients regarding common and serious--but not all possible--side effects to decrease complaints. Psychotherapy requires substantial skill to perform competently; psychotherapy and medication requires even greater sensitivity and does not mean that only half the usual attention can be paid to each modality.

A positive view of psychiatrists and psychiatry.

A review of the literature on the personalities, mental health, and professional status of psychiatrists was the basis of a questionnaire designed to assess perceptions of these characteristics by psychiatrists themselves and by their medical colleagues. The 374 physician respondents were divided into two groups, psychiatrists and nonpsychiatrists, and beliefs and perceptions were compared between the two groups and with findings from the research literature. Results revealed some differences in opinion between psychiatrists and nonpsychiatrists, most notably concerning the mental health of psychiatrists. This was also the area in which the literature was least conclusive. Findings indicated, however, that physicians across specialties have a positive overall opinion of psychiatrists and their professional worth, and that psychiatrists see themselves as healthy, effective, and useful practitioners.

Bipolar affective disorder. I. Comprehensive quantitative computed tomography.

Based on clinical similarities with schizophrenics and previous computed tomography (CT) studies that found distinct structural abnormalities in the brains of bipolar patients, we evaluated 26 DSM-III bipolar patients and 22 controls by CT, using quantitative measures of ventricular and sulcal size and of cerebral parenchymal density. Third ventricle size was increased, as was periventricular and cortical density. Comparison is made with results found in other psychotic conditions and the possible etiopathological significance discussed.

Bipolar affective disorder. II. EEG, neuropsychological, and clinical correlates of CT abnormality.

Since the clinical significance of CT abnormalities found in bipolar patients remains obscure, we studied 26 DSM-III bipolar patients who had specific CT abnormalities (third ventricle enlargement, and hyperdensity of the caudate, thalamus, anterior frontal white matter, and right temporal lobe) on numerous parameters such as EEG, the Halstead-Reitan Neuropsychological Battery, premorbid personality adjustment, family history of affective disorder, positive and negative symptoms, employment history, and response to lithium carbonate treatment. None of these measures could differentiate between the CT abnormal and CT normal subgroups. The implications of these findings are discussed.